Our Pipeline

Therapy Area Project - Indication Non-clinical Phase I Phase II Phase III Filed
Reproductive Health FE 999310 Infertility yes
FE 202767 Lactation yes
BARUSIBAN Implantation Support yes
REKOVELLE (recombinant human FSH) Infertility yes
MILPROSA Progesterone vaginal ring Luteal phase support yes
Urology TESTAVAN (testosterone gel) Male hypogonadism yes
Gastroenterology FE 203799 Indication to be determined yes
Endocrinology
Orthopaedics AMPLEX (B2A peptide + tricalcium phosphate ceramic granules) Foot & Ankle Fusion yes
PREFIX (B2A peptide + tricalcium phosphate ceramic granules) Lumbar Spine Fusion yes
CONDOLIASE (chrondroitin-sulfate-ABC endolyase) Radicular leg pain (e.g. sciatica) due to lumbar disc herniation yes
Other SELEPRESSIN Septic shock yes

Headquarters

FERRING INTERNATIONAL CENTER S.A.
CH. DE LA VERGOGNAUSAZ 50
1162 SAINT-PREX
SWITZERLAND

TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10

CONTACT

global locator